Stocks and Investing Stocks and Investing
Tue, February 2, 2021
Mon, February 1, 2021
Sun, January 31, 2021
Fri, January 29, 2021
Thu, January 28, 2021

David Risinger Maintained (ABBV) at Buy with Decreased Target to $116 on, Jan 28th, 2021


Published on 2024-10-27 15:24:31 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $120 to $116 on, Jan 28th, 2021.

David has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $110 on, Friday, December 11th, 2020


These are the ratings of the 6 analyists that currently disagree with David


  • Randall Stanicky of "RBC Capital" Initiated at Buy and Held Target at $129 on, Wednesday, January 6th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $128 on, Wednesday, December 16th, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $124 on, Friday, December 11th, 2020
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $120 on, Thursday, December 10th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $120 on, Monday, November 30th, 2020
  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020